Company Overview and News

1
Sonobuoy TechSystems Awarded $9.3M in Foreign Sales Contracts

6h asdnews
Ultra Electronics USSI, a subsidiary of Ultra Electronics Holdings plc (ULE) and Sparton Corporation (NYSE: SPA), announce the award of subcontracts valued at $9.3 millionfrom their ERAPSCO/Sonobuoy TechSystems joint venture. ERAPSCO/Sonobuoy TechSystems will provide manufacturing subcontracts in the amount of $4.5 million to Sparton DeLeon Springs, LLC and $4.8 million to Ultra Electronics USSI. Production will take place at Ultra Electronics USSI’s Columbia City, IN facility and Sparton’s DeLeon Springs, FL facility.
SPA SRI SPNRF

1
SPA / Sparton Corp. / GAMCO INVESTORS, INC. ET AL - null (Activist Investment)

2018-08-03 sec.gov
  SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SPA

1
SPA / Sparton Corp. / GAMCO INVESTORS, INC. ET AL - null (Activist Investment)

2018-08-03 sec.gov
  SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SPA

1
AIT Therapeutics Announces Start of Manufacturing of Ventilator Compatible NO Generator and Delivery System

2018-07-30 globenewswire
GARDEN CITY, N.Y. and REHOVOT, Israel, July 30, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, today announced that it has begun commercial development for its ventilator compatible NO generator and delivery system with Sparton Corporation, a leader in the design and manufacture of highly complex electromechanical devices.
SPA AITB SRI SPNRF

191
Stocks To Watch: Apple, Harley And Tesla On The Marquee

2018-07-28 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
YUM CAT BNPQY ILMN PGNX SLGL RGR 1128 ZNGA MVBFP MVBFO 1928 AKAM LNG FTSI JACK LKQ RECN SPA GPRO BNPZY BABA ITW NEXT SPG UTHR FCAU MGM FB FIT CAAP FRC TM CGNX DVN MDCO ATVI SJMHY MLCO PSBQ AGN AAPL RIG BIDU STRA LUV CBS WYNN CEPU HUD AWR WYNMF BNPQF HMC 0880 EOG BHI KHC INBK CCOI CAKE WYNMY CBOE HAFC CQP TWX PXD UAL RMD PSBH FUV DOV VLKAY SMG SQ BY TTWO AAL IDXX HOG CMG BRK.A BP MSBI FRT SJMHF PFE PG STX CHE WGO CCBG COO MYL UCFC CPLA QCRH GM RMD PII DAL MSCI LFUS OSS F XPO CMCSA SCHYF P COG TRTN DWDP MFSF MVBF 506186 GLXYENT BMRC TXT TELL SCHYY

1
SPA / Sparton Corp. 11-K/A

2018-07-17 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMI
SPA

1
SPA / Sparton Corp. / GAMCO INVESTORS, INC. ET AL - null (Activist Investment)

2018-07-13 sec.gov
  SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SPA

1
SPA / Sparton Corp. / GAMCO INVESTORS, INC. ET AL - null (Activist Investment)

2018-07-13 sec.gov
  SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SPA

2
Oncolytics: Significant Pipeline Value In The Fastest Growing Area Of Oncology.

2018-07-11 seekingalpha
Oncolytics Biotech Inc. is developing an intravenously delivered immuno-oncolytic virus called REOLYSIN (pelareorep). REOLYSIN is a non-pathogenic, proprietary isolate of the unmodified reovirus that: 1) induces selective tumor lysis in various solid tumors and 2) promotes an inflamed tumor phenotype through innate and adaptive immune responses-turning cold tumors “HOT”.
SPA ONCYF ONCY ONCYD PFS

7
SPA / Sparton Corp. 8-K (Current Report)

2018-07-09 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
SPA

1
SPA / Sparton Corp. 11-K

2018-06-26 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
SPA

0
SPA / Sparton Corp. SD

2018-05-28 sec.gov
SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SPA

1
SPA / Sparton Corp. / GAMCO INVESTORS, INC. ET AL - null (Activist Investment)

2018-05-27 sec.gov
  SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SPA

0
SPA / Sparton Corp. / GAMCO INVESTORS, INC. ET AL - null (Activist Investment)

2018-05-27 sec.gov
  SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SPA

0
Sparton and Raytheon Team on Next Generation Mine Neutralization System

2018-05-18 asdnews
Sparton Corporation (NYSE:SPA) announces it will team with Raytheon to support the design, test, and deployment of the next generation Barracuda Mine Neutralization system.
SPA SRI SPNRF

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

CUSIP: 847235108